Relationship between head and neck cancer therapy and some genetic endpoints

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

395

WORD

293

HTML

4000

Figures (1-3)

141

Sum=4829

Publishing Process of This Article

Item

Count

Browse

944

Download

936

Sum=1880

May 10, 2014 (publication date) through Sep 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. May 10, 2014; 5(2): 93-102
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.93

Full Size Figure Download Figure

Figure 1 Micronucleated lymphocytes. Stained with 5% Giemsa (increased × 400).

Citation: Minicucci EM, da Silva GN, Salvadori DMF. Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol 2014; 5(2): 93-102
URL: https://www.wjgnet.com/2218-4333/full/v5/i2/93.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i2.93